Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
PolyIran: PolyPill for CVD Prevention
NCT01271985Phase 3Completed
- Sponsor
- Tehran University of Medical Sciences
- Start
- Feb 2011
- Primary completion
- Jan 2019
- Modality
- Orthosteric Ligands
- Countries
- 1
01
Overview
A Phase 3 trial of aspirin, atorvastatin, hydrochlorothiazide, enalapril, valsartan in cardiovascular diseases (CVD), sponsored by Tehran University of Medical Sciences. Started Feb 2011; status: completed.
02
Drugs
aspirinatorvastatinhydrochlorothiazideenalaprilvalsartan
03
Conditions
cardiovascular diseases (CVD)
Beyond the preview
Go deeper on NCT01271985.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT01271985.